Incidence and Predictors of Angioedema in Elderly Hypertensive Patients at High Risk for Cardiovascular Disease: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Hypertensive Patients ◽

Elderly Hypertensive ◽

Elderly Hypertensive Patients

Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70439-5 ◽

2006 ◽

Vol 2006 ◽

pp. 205-206

Author(s):

R. Garrick

Keyword(s):

High Risk ◽

Calcium Channel ◽

Heart Attack ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Lipid Lowering ◽

Converting Enzyme ◽

Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Yearbook of Cardiology ◽

10.1016/s0145-4145(07)70036-9 ◽

2006 ◽

Vol 2006 ◽

pp. 64-66

Author(s):

W.J. Elliott

Keyword(s):

High Risk ◽

Calcium Channel ◽

Heart Attack ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Lipid Lowering ◽

Converting Enzyme ◽

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)—Correction

JAMA ◽

10.1001/jama.289.2.178a ◽

2003 ◽

Vol 289 (2) ◽

pp. 178

Keyword(s):

High Risk ◽

Calcium Channel ◽

Heart Attack ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Lipid Lowering ◽

Converting Enzyme ◽

Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs. a Diuretic. A Report From the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

ACC Current Journal Review ◽

10.1016/j.accreview.2005.08.026 ◽

2005 ◽

Vol 14 (8) ◽

pp. 15-16

Author(s):

M. Rahman ◽

S. Pressel ◽

B.R. Davis

Keyword(s):

High Risk ◽

Calcium Channel ◽

Heart Attack ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Lipid Lowering ◽

Converting Enzyme ◽

Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Yearbook of Cardiology ◽

10.1016/s0145-4145(08)70041-8 ◽

2007 ◽

Vol 2007 ◽

pp. 75-77

Author(s):

W.J. Elliott

Keyword(s):

High Risk ◽

Heart Attack ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Lipid Lowering ◽

Converting Enzyme ◽

Hypertensive Patients ◽

Clinical Events

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

JAMA ◽

10.1001/jama.288.23.2981 ◽

2002 ◽

Vol 288 (23) ◽

pp. 2981-2997 ◽

Cited By ~ 3839

Author(s):

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group

Keyword(s):

High Risk ◽

Calcium Channel ◽

Heart Attack ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Lipid Lowering ◽

Converting Enzyme ◽

Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Hypertension ◽

10.1161/01.hyp.0000231662.77359.de ◽

2006 ◽

Vol 48 (3) ◽

pp. 374-384 ◽

Cited By ~ 104

Author(s):

Frans H.H. Leenen ◽

Chuke E. Nwachuku ◽

Henry R. Black ◽

William C. Cushman ◽

Barry R. Davis ◽

...

Keyword(s):

High Risk ◽

Heart Attack ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Lipid Lowering ◽

Converting Enzyme ◽

Hypertensive Patients ◽

Clinical Events

The Prevalence of Reduced Glomerular Filtration Rate in Older Hypertensive Patients and Its Association With Cardiovascular DiseaseA Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Archives of Internal Medicine ◽

10.1001/archinte.164.9.969 ◽

2004 ◽

Vol 164 (9) ◽

pp. 969 ◽

Cited By ~ 55

Author(s):

Mahboob Rahman

Keyword(s):

Cardiovascular Disease ◽

Glomerular Filtration Rate ◽

Glomerular Filtration ◽

Heart Attack ◽

Filtration Rate ◽

Lipid Lowering ◽

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

ACC Current Journal Review ◽

10.1016/s1062-1458(03)00034-5 ◽

2003 ◽

Vol 12 (2) ◽

pp. 37

Keyword(s):

High Risk ◽

Calcium Channel ◽

Heart Attack ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Lipid Lowering ◽

Converting Enzyme ◽

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)—Correction

JAMA ◽

10.1001/jama.291.18.2196 ◽

2004 ◽

Vol 291 (18) ◽

pp. 2196 ◽

Cited By ~ 3

Keyword(s):

High Risk ◽

Calcium Channel ◽

Heart Attack ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Lipid Lowering ◽

Converting Enzyme ◽